OQROStart free trial
Politician trade (House)

Johnson & Johnson (JNJ): Rep. John R. Curtis (UT03) disclosed a sale $1K–$15K

Rep. John R. Curtis (UT03) disclosed a sale of Johnson & Johnson in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
21 days
Disclosure lag
Traded
Sep 13, 2023
Disclosed
Oct 4, 2023

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 2, 2019CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  2. May 4, 2021CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  3. Jul 14, 2023CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  4. Aug 7, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  5. Aug 10, 2023CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  6. Aug 22, 2023CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  7. Sep 7, 2023Congress · 2 peopleMembers of Congress: 2 purchases
  8. Sep 8, 2023CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  9. Sep 11, 2023CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
  10. Sep 13, 2023 · this disclosureCongressDisclosed sale of JNJ — reported range $1,001 - $15,000

What came next

  1. Sep 21, 2023CongressDisclosed sale of JNJ — reported range $100,001 - $250,000
  2. Sep 26, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  3. Oct 16, 2023CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  4. Oct 24, 2023CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  5. Nov 7, 2023FDARecall: Abiomed Kit, 14Fr Introducer, 13cm&25cm, Sterile Part of Pump Set (0048-0040, 0048-0045, 1000080)-Introducer(s) are intended for introduction of the Impella Ca…
  6. Nov 7, 2023FDARecall: Oscor Intro Kit, 14Fr x 13 and 25 cm Part of Pump Set (0048-0040)-Introducer(s) are intended for introduction of the Impella Catheter into the body. Part Numbe…
  7. Nov 9, 2023FDAFDA device clearance: SYMPHONY OCT System
  8. Nov 13, 2023FDAFDA device clearance: INHANCE Shoulder System Convertible Glenoid Inserts, INHANCE Convertible Glenoid
  9. Nov 28, 2023FDAFDA device clearance: Monarch Bronchoscope
  10. Dec 5, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  11. Dec 6, 2023FDARecall: Impella Connect, software portal for online device management that allows clinicians and Impella support staff to remotely view Impella data.
  12. Dec 11, 2023FDAFDA device clearance: ATTUNE® Porous Fixed Bearing Tibial Base, Medialized Dome Patella and Medialized Anatomic Patella with AFFIXIUM™ 3DP Technology
  13. Dec 11, 2023FDARecall: ENDOPATH ECHELON 45mm RELOADS WITH GRIPPING SURFACE TECHNOLOGY (GST), ECHELON Endopath Stapler, Endoscopic Linear Cutter Reload (+Gripping Surface technology),…
  14. Dec 12, 2023FDAFDA device clearance: TriALTIS™ Spine System
  15. Dec 12, 2023FDARecall: TECNIS Toric II OptiBlue IOL Models ZCW
  16. Dec 14, 2023FDAFDA device clearance: VELYS™ Robotic-Assisted Solution
  17. Dec 19, 2023FDAFDA drug approval: Erleada
  18. Dec 19, 2023FDAFDA device clearance: CORAIL Cemented Femoral Stem
  19. Dec 27, 2023FDARecall: Impella catheters - Intravascular micro axial blood pumps that support a patient's circulatory system. (1) Product Code 005042 - Impella 2.5 (2) Product Code 0…
  20. Dec 27, 2023FDARecall: Impella catheters - Intravascular micro axial blood pumps that support a patient's circulatory system. (1) Product Code 005042 - Impella 2.5 (2) Product Code 0…
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 119 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Rep. John R. Curtis (UT03)

The full history of Rep. John R. Curtis (UT03) is on the profile page.

How this filing works

Explore the data

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data